Skip to main content

Topic

Research and Development

79 published works

  1. Canada in Focus

    Alberta announce $166 million Innovation Employment Grant for research and development

    By Michael Styczen, P.Eng., Sandra Mah, Shannon Peddlesden

    The government of Alberta has introduced an Innovation Employment Grant (“IEG”) to complement its Job Creation Tax Cut (“JCTC”) in an effort to stimulate investment and expand opportunities in Alberta.…

  2. Health Law Prof Blog

    A Contract for New Vaccine R&D under COVID-19

    By Katharine Van Tassel

    Ji-Hung Choi (Eastern Michigan University), Jiho Yoon (Chung-Ang University), Ju Myung Song (University of Massachusetts), A Contract for New Vaccine R&D under COVID-19, SSRN:This paper analyzes an incentive contract for…

  3. Nano and Other Emerging Chemical Technologies Blog

    Explanatory Statement for EPA Appropriations Bill Directs EPA Administrator to Involve FDA in NanoEHS Research

    By Lynn L. Bergeson, Carla N. Hutton

    On November 10, 2020, the Senate Committee on Appropriations released 12 fiscal year (FY) 2021 appropriations bills and explanatory statements.  The bill for the Department of the Interior, environment, and…

  4. China Law Insight

    澳大利亚研发税收激励政策简析

    By King & Wood

    由于1)澳大利亚政府逐步推行的各项有力措施,例如联邦政府医学研究与创新战略、国家创新与科学计划等;2)澳大利亚多种族的人群结构使得数据样本更为广泛;3)澳大利亚得天独厚的地理优势和时区优势等,澳大利亚成为近年来医疗行业临床研究极富吸引力的地区。其中,澳大利亚政府推行的研发税收抵免优惠政策(R&D Tax Incentive,下称“R&D TI”),更以其优惠的抵免政策和高效的审批流程,吸引着越来越多的外国生物医药企业赴澳开展药物研发临床试验活动。本文主要针对R&D TI的规定和适用情形做出简要介绍和分析。

  5. Dashboard Insights

    Top Impacts of the Pandemic on Autonomous Vehicle Research and Development

    By Chethan K. Srinivasa, Pakin Pongcheewin

    No industry has been immune to the pandemic, and it has certainly had a significant impact on Autonomous Vehicle (AV) Research and Development. AV companies have laid-off workers, delayed testing,…

  6. Health Law Prof Blog

    The COVID-19 Pandemic: R&D and Intellectual Property Management for Access to Diagnostics, Medicines and Vaccines

    By Katharine Van Tassel

    Viviana Munoz Tellez (South Centre), The COVID-19 Pandemic: R&D and Intellectual Property Management for Access to Diagnostics, Medicines and Vaccines, SSRN:The ongoing rapid spread of COVID-19 is challenging the capacity…

  7. Nano and Other Emerging Chemical Technologies Blog

    Video and Slides Available from National Academies Briefing Webinar on Quadrennial Review of NNI

    By Lynn L. Bergeson, Carla N. Hutton

    On June 9, 2020, the National Academies of Sciences, Engineering, and Medicine (National Academies) held a briefing webinar featuring its report, A Quadrennial Review of the National Nanotechnology Initiative.  During…

  8. Triage Health Law

    COVID-19: the EC extends the State aid Temporary Framework

    By Oliver Geiss

    The European Commission (EC) has recently adopted an amendment that extends the State aid Temporary Framework (described in our last blog post here) by adding five further types of aid…

  9. Inside Global Tech

    AI Update: White House Announces RFI on Improving AI R&D Data and Models

    By Inside Global Tech

    On July 10, 2019, the White House Office of Management and Budget (“OMB”) published a Request for Information (“RFI”) in the Federal Register, requesting comments on how to improve Federal…

  10. The Employer Report

    Human Resources & Antitrust: A New Risk Is Emerging

    By William F. Dugan, Meredith L. Kaufman

    Baker McKenzie's antitrust specialists see new areas of focus for antitrust agencies around the globe: Procurement, HR and R&D. Is your company prepared? With increased scrutiny from antitrust regulators, companies…